2026-01817Proposed Rule

Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP

Published Date: 1/29/2026

Proposed Rule

Summary

The government wants your thoughts on updating rules that stop sneaky deals and freebies in Medicare and state health programs, especially for new drug sales like those on TrumpRx. This could change how drug companies sell directly to patients, making meds fairer and cheaper for Americans. Speak up by March 30, 2026, to help shape these important changes that could save money and protect patients.

Analyzed Economic Effects

4 provisions identified: 3 benefits, 0 costs, 1 mixed.

TrumpRx: Direct-to-Consumer Drug Platform

HHS is establishing TrumpRx, a platform to let American patients buy prescription drugs directly from manufacturers at a “Most‑Favored‑Nation” price, bypassing middlemen. HHS says removing government obstacles to ensure access to affordable prescription drugs through TrumpRx is a key priority and is seeking public input through this request for information.

Potential Changes to Anti‑Kickback Safe Harbors

The OIG is asking whether to modify or add safe harbors to the Federal anti‑kickback statute (42 CFR 1001.952) and exceptions to the Beneficiary Inducements CMP (42 CFR 1003.110) to support direct‑to‑consumer manufacturer drug sales while protecting against fraud and abuse. The agency requests public comment by March 30, 2026.

Safe Harbor for Personal Services/Management Contracts

The RFI notes that existing safe harbors relevant to direct‑to‑consumer programs may include the personal services and management contracts safe harbor (42 CFR 1001.952(d)) and asks for input on conditions that should be included in any new or modified safe harbor.

Guidance vs Regulation for DTC Sales

OIG is asking whether clarifying guidance (for example, an amended Special Advisory Bulletin, FAQs, or other guidance) might be sufficient instead of new regulations to address direct‑to‑consumer sales to people covered by Federal health care programs. The RFI seeks examples and feedback and sets a comment deadline of March 30, 2026.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Comments Due
1/29/2026
3/30/2026

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Inspector General Office, Health and Human Services Department
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in